The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa

Current HIV/AIDS Reports

Volumn 3, Issue 4, 2006, Pages 187-194

  Kaida, Angela ^a   Andia, Irene ^b   Maier, Marissa ^b   Strathdee, Steffanie A ^b   Bangsberg, David R ^b   Spiegel, Jerry ^b   Bastos, Francisco I ^b   Gray, Glenda ^b   Hogg, Robert ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

AFRICA SOUTH OF THE SAHARA; BONGAART PROXIMATE DETERMINANT OF FERTILITY FRAMEWORK; CHILDBIRTH; CONCEPTUAL FRAMEWORK; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; FEMALE INFERTILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY RATE; REVIEW;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CONTRACEPTION BEHAVIOR; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; FERTILITY; HIV INFECTIONS; HUMANS; INFERTILITY, FEMALE; MARITAL STATUS; PREGNANCY; PREGNANCY OUTCOME;

EID: 33750455825     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-006-0015-0     Document Type: Review

References (72)

1. Joint United Nations Programme on HIV/AIDS: AIDS epidemic update: December 2005. Geneva: World Health Organization; 2005.
2. Allen S: Why is fertility an issue for HIV-infected and at-risk women? J Acquir Immune Defic Syndr 2005, 38(Suppl 1):S1-S3.
3. Zaba B, Gregson S: Measuring the impact of HIV on fertility in Africa. AIDS 1998, 12(Suppl 1):S41-S45.
4. Lewis JJ, Ronsmans C, Ezeh A, Gregson S: The population impact of HIV on fertility in sub-Saharan Africa. AIDS 2004, 18(Suppl 2):S35-S43. A recent and updated review article measuring the impact of HIV on fertility in Africa.
5. WHO 2003-08: A programme of quiet thunder takes shape [editorial]. Lancet 2003, 362:179.
6. World Health Organization: "3 by 5" progress report. Geneva: UNAIDS/WHO; 2004.
7. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
8. Hogg RS, Heath KV, Yip B, et al.: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998, 279:450-454.
9. Seyler C, Anglaret X, Dakoury-Dogbo N, et al.: Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d'Ivoire. Antivir Ther 2003, 8:385-393.
10. Wools-Kaloustian K, Kimaiyo S, Diero L, et al.: Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006, 20:41-48.
11. Bongaarts J, Potter RG: Fertility, Biology, and Behavior: An Analysis of the Proximate Determinants. New York: Academic Press; 1983.
12. Boerma JT, Weir SS: Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. J Infect Dis 2005, 191(Suppl 1):S61-S67.
13. Fabiani M, Nattabi B, Ayella EO, et al.: Differences in fertility by HIV serostatus and adjusted HIV prevalence data from an antenatal clinic in northern Uganda. Trop Med Int Health 2006, 11:182-187.
14. Ross A, Van der Paal L, Lubega R: HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS 2004, 18:799-804.
15. Sedgh G, Larsen U, Spiegelman D, et al.: HIV-1 disease progression and fertility in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2005, 39:439-445.
16. Loko MA, Toure S, Dakoury-Dogbo N, et al.: Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Cote d'Ivoire: a 7-year cohort study. AIDS 2005, 19:443-445.
17. van Benthem BH, De Vincenzi I, Delmas MC, et al.: Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women. AIDS 2000, 14:2171-2178.
18. Forsyth BW, Davis JA, Freudigman KA, et al.: Pregnancy and birth rates among HIV-infected women in the United States: the confounding effects of illicit drug use. AIDS 2002, 16:471-479.
19. De Vincenzi I, Jadand C, Couturier E, et al.: Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS 1997, 11:333-338.
20. D'Ubaldo C, Pezzotti P, Rezza G, et al.: Association between HIV-1 infection and miscarriage: a retrospective study. DIANAIDS Collaborative Study Group. AIDS 1998, 12:1087-1093.
21. Thackway SV, Furner V, Mijch A, et al.: Fertility and reproductive choice in women with HIV-1 infection. AIDS 1997, 11:663-667.
22. Hankins C, Tran T, Lapointe N: Sexual behaviour and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:479-487.
23. Lee LM, Wortley PM, Fleming PL, et al.: Duration of human immunodeficiency virus infection and likelihood of giving birth in a Medicaid population in Maryland. Am J Epidemiol 2000, 151:1020-1028.
24. Blair JM, Hanson DL, Jones JL, Dworkin MS: Trends in pregnancy rates among women with human immunodeficiency virus. Obstet Gynecol 2004, 103:663-668. A cohort study measuring trends in incidence of pregnancy among women with HIV infection in America before and during the HAART era.
25. Massad LS, Springer G, Jacobson L, et al.: Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS 2004, 18:281-286.
26. Fapohunda ER, Todaro MP: Family structure, implicit contracts, and the demand for children in southern Nigeria. Population and Development Review 1998, 14:571-594.
27. Gregson S, Zaba B, Hunter SC: The Impact of HIV-1 on Fertility in Sub-Saharan Africa: Causes and Consequences. http://www.un.org/esa/population/ publications/completing-fertility/RevisedZabapaper.PDF. Accessed March 20, 2006. A review article investigating the causes and consequences of HIV on fertility in sub-Saharan Africa.
28. Ntozi JPM: Impact of HIV/AIDS on Fertility in Sub-Saharan Africa. http://www.uneca.org/eca_resources/major_eca_websites/icpd/fourth/fc4-05. %20doc%20impact %20hiv%20on%20fertility.htm. Accessed April 1, 2006.
29. Stover J: Revising the proximate determinants of fertility framework: what have we learned in the past 20 years? Stud Fam Plann 1998, 29:255-267.
30. Gage AJ, Meekers D: Sexual activity before marriage in sub-Saharan Africa. Soc Biol 1994, 41:44-60.
31. Garenne M, Zwang J: Premarital fertility in Namibia: trends, factors and consequences. J Biosoc Sci 2006,38:145-167.
32. Asiimwe-Okiror G, Opio AA, Musinguzi J, et al.: Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 1997, 11:1757-1763.
33. Mukiza-Gapere J, Ntozi JP: Impact of AIDS on marriage patterns, customs and practices in Uganda. Health Transit Rev 1995, 5(Suppl):201-208.
34. Gregson S, Anderson RM, Ndlovu J, et al.: Recent upturn in mortality in rural Zimbabwe: evidence for an early demographic impact of HIV-1 infection? AIDS 1997, 11:1269-1280.
35. Gregson S, Zhuwau T, Anderson RM, et al.: Age and religion selection biases in HIV-1 prevalence data from antenatal clinics in Manicaland, Zimbabwe. Cent Afr J Med 1995, 41:339-346.
36. Ntozi JPM, Nakanaabi IM, Lubaale YAM: Fertility levels and trends in the face of the AIDS epidemic in Uganda. Health Transit Rev 1997, 7(Suppl):145-155.
37. Porter L, Hao L, Bishai D, et al.: HIV status and union dissolution in sub-Saharan Africa: the case of Rakai, Uganda. Demography 2004, 41:465-482.
38. Pebley A, Mbugua W: Polygyny and fertility in sub-Saharan Africa. In Reproduction and Social Organization in Sub-Saharan Africa. Edited by Lesthaeghe RJ. Berkley, CA: University of California Press; 1989:338-364.
39. Larsen U: A comparative study of the levels and differentials of fertility in Cameroon, Kenya and Sudan. In Reproduction and Social Organization in Sub-Saharan Africa. Edited by Lesthaeghe RJ. Berkley, CA: University of California Press; 1989:167-206.
40. Arya OP, Nsanzumuhire H, Taber SR: Clinical, cultural, and demographic aspects of gonorrhoea in a rural community in Uganda. Bull World Health Organ 1973, 49:587-595.
41. Larsen U: Sterility in sub-Saharan Africa. Popul Stud 1994, 48:459-474.
42. Temmerman M, Plummer FA, Mirza NB, et al.: Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990, 4:1087-1093.
43. Leroy V, Ladner J, Nyiraziraje M, et al.: Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS 1998, 12:643-650.
44. Mayaud P, Mosha F, Todd J, et al.: Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 1997, 11:1873-1880.
45. Wawer MJ, Sewankambo NK, Serwadda D, et al.: Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999, 353:525-535.
46. Garnett GP, Swinton J, Brunham RC, Anderson RM: Gonococcal infection, infertility, and population growth: II. The influence of heterogeneity in sexual behaviour. IMA J Math Appl Med Biol 1992, 9:127-144.
47. Becker S, Rutstein S, Labbok MH: Estimation of births averted due to breast-feeding and increases in levels of contraception needed to substitute for breast-feeding. J Biosoc Sci 2003, 35:559-574.
48. Desgrees-du-Lou A, Brou H: Resumption of sexual relations following childbirth: norms, practices, and reproductive health issues in Abidjan, Cote d'Ivoire. Reprod Health Matters 2005, 13:155-163.
49. Centers for Disease Control and Prevention: Family planning methods and practice: Africa, edn 2. Atlanta: United States Department of Health and Human Services; 2000.
50. Cleland JG, Ali MM, Capo-Chichi V: Post-partum sexual abstinence in West Africa: implications for AIDS-control and family planning programmes. AIDS 1999, 13:125-131.
51. Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R: Sexual behaviour in developing countries: implications for HIV control. AIDS 1995, 9:1171-1175.
52. Gaillard P, Folwer MG, Dabis F: Use of antiretroviral drugs to prevent HIV-1 transmission through breastfeeding: from animal studies to randomized clinical trials. J Acquir Defic Syndr 2004, 35:178-187.
53. Moatti JP, Prudhomme J, Traore DC, et al.: Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d'Ivoire. AIDS 2003, 17(Suppl 3):S69-S77.
54. Gray RH, Wawer MJ, Serwadda D, et al.: Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998, 351:98-103.
55. Widy-Wirski R, Berkley S, Downing R, et al.: Evaluation of the WHO clinical case definition for AIDS in Uganda. JAMA 1988, 260:3286-3289.
56. Chirgwin KD, Feldman J, Muneyyirci-Delale O, et al.: Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:489-494.
57. Krieger JN, Coombs RW, Collier AC, et al.: Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 1991, 164:464-469.
58. Martin PM, Gresenguet G, Herve VM, et al.: Decreased number of spermatozoa in HIV-1-infected individuals. AIDS 1992, 6:130.
59. Gray G, Bastos F, Andia I, et al.: Determinants of HAART use among women of reproductive age in Brazil, Uganda, and South Africa [abstract]. Paper presented at the XVI International AIDS Conference. Toronto; August 13-18, 2006.
60. Terceira N, Gregson S, Zaba B, Mason PR: The contribution of HIV to fertility decline in rural Zimbabwe, 1985-2000. Popul Stud 2003, 57:149-164.
61. Lutalo T, Kidugavu M, Wawer MJ, et al.: Trends and determinants of contraceptive use in Rakai District, Uganda, 1995-1998. Stud Fam Plann 2000, 31:217-227.
62. Okeibunor JC: Threat of AIDS and Condom Use in a Nigerian Urban Community: Implications for Fertility Regulation in Nigeria. Dakar, Senegal: Union for African Population Studies; 1999.
63. Glynn JR, Buve A, Carael M, et al.: Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr 2000, 25:345-352.
64. Rutenberg N, Biddlecom AE, Kaona AD: Reproductive decision-making in the context of HIV and AIDS: a qualitative study in Ndola, Zambia. Int Fam Plan Perspect 2000, 26:124-130.
65. Baylies C: The impact of HIV on family size preference in Zambia. Reprod Health Matters 2000, 8:77-86.
66. Panozzo L, Battegay M, Friedl A, et al.: High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner-two challenging issues. Swiss Med Wkly 2003, 133:124-127.
67. Brocklehurst P, French R: The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998, 105:836-848.
68. Suy A, Martinez E, Coll O, et al.: Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006, 20:59-66.
69. Tuomala RE, Shapiro DE, Mofenson LM, et al.: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002, 346:1863-1870.
70. Tuomala RE, Watts DH, Li D, et al.: Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 2005, 38:449-473.
71. Thorne C, Newell ML: The safety of antiretroviral drugs in pregnancy. Expert Opin Drug Saf 2005, 4:323-335.
72. Desgrees-du-Lou A, Msellati P, Ramon R, et al.: HIV-1 infection and reproductive history: a retrospective study among pregnant women, Abidjan, Cote d'Ivoire, 1995-1996. Ditrame Project. Int J STD AIDS 1998, 9:452-456.